ArticleRenal failure2026
Long-term outcome of stenting for the iliac vein stenosis with ipsilateral arterio-venous graft; a case series.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the possible etiology and evaluate the technical and clinical outcomes of using bare metal stents for the treatment of central venous stenosis (CVS) in the lower extremity with ipsilateral hemodialysis access.
methodsA single-center retrospective analysis of a small case series was conducted in hemodialysis patients with lower extremity arteriovenous grafts (AVG) who were treated with bare metal stents (BMS) for symptomatic iliac vein stenosis between April 2016 and June 2021. Patients' demographic data, technical details, adverse events, clinical outcomes, and imaging data were recorded.
resultsThe study cohort comprised seven females and four males, with a mean age of 58.8 ± 13.4 years. Preoperative lower limb venography was performed in nine patients scheduled for AVG creation. With the exception of one case demonstrating left iliac vein compression, the iliac veins were patent in all other patients. Symptoms of lower limb swelling developed at a mean interval of 9.40 ± 5.83 months (range: 3-20 months) following AVG placement. Eight cases had a concomitant history of temporary ipsilateral femoral vein catheterization. Lesion characteristics included nine stenotic lesions and two occlusive lesions. All patients were treated with SMART Control stents (Cordis Corp, USA). The technical success rate was 100%, and symptomatic relief was achieved in all cases. Over a mean follow-up period of 47.8 ± 31.7 months (range: 10-123 months), the target lesion primary patency was 100% (one-side confidence interval [CI] = 0.74,1).
conclusionsUsing BMS is a safe and effective method to treat iliac vein stenosis with ipsilateral AVG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.